Rossari Biotech Limited (BOM:543213)
India
· Delayed Price · Currency is INR 695.65
+9.20 (1.34%)
At close: May 13, 2025
Rossari Biotech Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 12, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2020 |
| Market Capitalization | 38,776 | 33,476 | 37,399 | 32,878 | 50,189 | 53,775 | Upgrade
|
| Market Cap Growth | -10.49% | -10.49% | 13.75% | -34.49% | -6.67% | - | Upgrade
|
| Enterprise Value | 39,811 | 34,283 | 37,924 | 32,853 | 49,805 | 52,708 | Upgrade
|
| Last Close Price | 700.40 | 604.05 | 674.03 | 594.60 | 911.87 | 1035.32 | Upgrade
|
| PE Ratio | 28.43 | 24.55 | 28.62 | 30.65 | 51.39 | 67.04 | Upgrade
|
| PS Ratio | 1.86 | 1.61 | 2.04 | 1.99 | 3.38 | 7.58 | Upgrade
|
| PB Ratio | 3.27 | 2.82 | 3.57 | 3.59 | 6.23 | 13.16 | Upgrade
|
| P/TBV Ratio | 4.12 | 3.56 | 4.76 | 5.13 | 9.22 | 13.60 | Upgrade
|
| P/FCF Ratio | - | - | - | 27.70 | - | - | Upgrade
|
| P/OCF Ratio | 28.21 | 24.36 | 86.46 | 21.69 | 170.96 | 112.58 | Upgrade
|
| EV/Sales Ratio | 1.91 | 1.65 | 2.07 | 1.98 | 3.36 | 7.43 | Upgrade
|
| EV/EBITDA Ratio | 14.96 | 12.93 | 15.73 | 15.37 | 28.17 | 42.87 | Upgrade
|
| EV/EBIT Ratio | 20.01 | 17.31 | 20.76 | 21.67 | 38.54 | 52.58 | Upgrade
|
| EV/FCF Ratio | -188.96 | - | - | 27.68 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.18 | 0.18 | 0.11 | 0.08 | 0.01 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.82 | 0.82 | 0.49 | 0.34 | 0.05 | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.62 | - | - | Upgrade
|
| Asset Turnover | 1.20 | 1.20 | 1.25 | 1.26 | 1.63 | 1.37 | Upgrade
|
| Inventory Turnover | 4.50 | 4.50 | 5.53 | 6.22 | 7.80 | 6.05 | Upgrade
|
| Quick Ratio | 1.10 | 1.10 | 1.17 | 1.45 | 1.25 | 1.55 | Upgrade
|
| Current Ratio | 1.94 | 1.94 | 1.99 | 2.07 | 2.07 | 2.36 | Upgrade
|
| Return on Equity (ROE) | 12.21% | 12.21% | 13.32% | 12.47% | 16.10% | 23.02% | Upgrade
|
| Return on Assets (ROA) | 7.14% | 7.14% | 7.77% | 7.22% | 8.88% | 12.13% | Upgrade
|
| Return on Capital (ROIC) | 9.63% | 9.63% | 10.60% | 10.51% | 13.21% | 16.43% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.60% | 14.60% | 15.90% | 14.90% | 13.40% | 24.40% | Upgrade
|
| Earnings Yield | 3.52% | 4.07% | 3.49% | 3.26% | 1.95% | 1.49% | Upgrade
|
| FCF Yield | -0.54% | -0.63% | -2.35% | 3.61% | -0.18% | -0.19% | Upgrade
|
| Dividend Yield | 0.07% | 0.08% | 0.07% | 0.08% | 0.06% | 0.05% | Upgrade
|
| Payout Ratio | 2.03% | 2.03% | 2.11% | 2.57% | 2.82% | 3.16% | Upgrade
|
| Buyback Yield / Dilution | -0.08% | -0.08% | 0.05% | -0.33% | -6.37% | -5.16% | Upgrade
|
| Total Shareholder Return | -0.01% | 0.00% | 0.13% | -0.24% | -6.31% | -5.12% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.